Translational Life Sciences Overview

  • Status
  • Private

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

Translational Life Sciences General Information

Description

Developer of proprietary formulations that contain restricted substances such as psilocybin and cannabis to serve unmet medical needs in the market. The company offers research services to treat opioid dependence, psychotic illness, pain management as well as traumatic brain injuries such as concussions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Vancouver, British Columbia
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Translational Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Translational Life Sciences‘s full profile, request access.

Request a free trial

Translational Life Sciences Executive Team (2)

Name Title Board Seat Contact Info
William Panenka Founder
Caroline MacCallum Chief Medical Officer
To view Translational Life Sciences’s complete executive team members history, request access »

Translational Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Translational Life Sciences‘s full profile, request access.

Request a free trial